Utility of PET-CT on radiotherapy planning of head and neck cancer. Our initial experience

被引:5
|
作者
Bellon Guardia, M. E. [1 ]
Perez Romasanta, L. [2 ]
Garcia Vicente, A. M. [1 ]
Talavera Rubio, M. P. [1 ]
Palomar Munoz, A. [1 ]
Gonzalez Garcia, B. [1 ]
Poblete Garcia, V. M. [1 ]
Soriano Castrejon, A. [1 ]
机构
[1] Hosp Gen Ciudad Real, Nucl Med Serv, Ciudad Real, Spain
[2] Hosp Gen Ciudad Real, Serv Oncol Radioterap, Ciudad Real, Spain
来源
REVISTA ESPANOLA DE MEDICINA NUCLEAR | 2010年 / 29卷 / 04期
关键词
Radiotherapy planning; Head and neck tumors; Positron emission tomography-computed tomography; POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; GROSS TUMOR VOLUME; FDG-PET; COMPUTED-TOMOGRAPHY; FLUORO-DEOXYGLUCOSE; RECURRENT HEAD; IMPACT; SEGMENTATION; DEFINITION;
D O I
10.1016/j.remn.2010.03.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To describe the methods used for the incorporation of FDG-PET-CT on radiotherapy planning of patients with head and neck cancer and also to evaluate the impact of FOG-PET-CT on staging and tumor volume definition. Material and methods: A prospective study in which 20 patients with head and neck tumor submitted for radiotherapy treatment were included. All underwent a whole body PET- CT (GE DSTE 16) for staging and restaging, also acquiring an additional 3 h delayed PET image with diagnostic CT parameters for planning. A CT scan with diagnostic protocol. tabletop available for radiotherapy treatment and the same personalized head-shoulder mask were used in the latter. Lymph node involvement and/or distant involvement were evaluated, considering the changes in staging. We also evaluated the differences in volumes obtained between the different techniques. The threshold value used for delineating PET gross tumor volume (GTV) was empirically established and ranged from 20-40% of the maximum SUV. Results: Radiotherapy planning was performed with PET-CT in 20 patients between October 2007 to September 2008. A total of 29 lesions (18 primary lesions because 2 patients were excluded as no tumor was observed on the PET CT images, and 11 nodes). The most frequent location was oropharynx (5 patients). Mean maxSUV of the 29 lesions was 14.4 (range 5.0 and 26.4). No statistically significant differences were found between the GTV PET and GTV CT (mean 21.9 cm(3) and 19.3 cm(3), respectively). PET-CT modified the staging in 20% of the patients, with a diagnostic and therapeutic impact of 50 and 25%, respectively. Conclusion: The incorporation of PET-CT in routine radiotherapy planning is a promising technique that requires close collaboration between the nuclear medicine and radiotherapy oncology departments. PET-CT achieves better staging in patients and has a significant diagnostic and therapeutic impact. The use of the hybrid technique avoids problems arising from co-registry as well as a second examination for planning with the consequent advantage for the patient. Nonetheless, more prospective and randomized studies with pathology specimens are needed to evaluate the real impact in the tumor volume definition. (C) 2009 Elsevier Espana, S.L. and SEMNIM. All rights reserved.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [31] Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT
    Ireland, Rob H.
    Dyker, Karen E.
    Barber, David C.
    Wood, Steven M.
    Hanney, Michael B.
    Tindale, Wendy B.
    Woodhouse, Neil
    Hoggard, Nigel
    Conway, John
    Robinson, Martin H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 952 - 957
  • [32] PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer
    Wong, Wai Lup
    SEMINARS IN NUCLEAR MEDICINE, 2020, 51 (01) : 13 - 25
  • [33] PET/MRI in head and neck cancer: initial experience
    Ivan Platzek
    Bettina Beuthien-Baumann
    Matthias Schneider
    Volker Gudziol
    Jens Langner
    Georg Schramm
    Michael Laniado
    Jörg Kotzerke
    Jörg van den Hoff
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 6 - 11
  • [34] PET/MRI in head and neck cancer: initial experience
    Platzek, Ivan
    Beuthien-Baumann, Bettina
    Schneider, Matthias
    Gudziol, Volker
    Langner, Jens
    Schramm, Georg
    Laniado, Michael
    Kotzerke, Joerg
    van den Hoff, Joerg
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) : 6 - 11
  • [35] Critical review of PET-CT for radiotherapy planning in lung cancer
    Senan, S
    De Ruysscher, D
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (03) : 345 - 351
  • [36] FDG PET-CT imaging in head and neck paragangliomas: A centre experience
    Boughdad, Sarah
    O'Connor, Ann
    Cook, Gary J.
    Pike, Lucy
    Connor, Steve
    Obholzer, Rupert
    Warbey, Victoria
    CLINICAL ENDOCRINOLOGY, 2021, 95 (02) : 315 - 322
  • [37] Impact of PET-CT on staging of patients with head and neck cancer during radiotheraphy planning.
    Geraldo, L.
    Fernandez, A.
    Camacho, V.
    Farre, N.
    Ruiz, A.
    Eudaldo, T.
    Domenech, A.
    De Vega, J.
    Carrio, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S226 - S227
  • [38] THE IMPACT OF PET-CT IMAGING IN RADIOTHERAPY PLANNING FOR ESOPHAGEAL CANCER
    Nishioka, A.
    Ogawa, Y.
    Kariya, S.
    Tadokoro, M.
    Nakatani, K.
    Tsuzuki, K.
    Ue, H.
    Hamada, N.
    Kubota, K.
    Fukumoto, M.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S358 - S358
  • [39] PET/CT in Surgical Planning for Head and Neck Cancer
    Strohl, Madeleine P.
    Ha, Patrick K.
    Flavell, Robert R.
    Yom, Sue S.
    SEMINARS IN NUCLEAR MEDICINE, 2020, 51 (01) : 50 - 58
  • [40] Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer
    Casselden, Elizabeth
    Sheerin, Fintan
    Winter, Stuart C.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (01) : 243 - 247